Silver Book Fact

Savings from flu vaccine

Vaccination for influenza resulted in an average annual cost savings of $13.66 per healthy working adult vaccinated.

Nichol, Kristin L. Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza. JAMA Intern Med. 2001; 161(5): 749-59. http://archinte.jamanetwork.com/article.aspx?articleid=647568

Reference

Title
Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza
Publication
JAMA Intern Med
Publication Date
2001
Authors
Nichol, Kristin L.
Volume & Issue
Volume 161, Issue 5
Pages
749-59
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Only a 20% reduction in drug-resistant infections would save $3.2 – $5.2 billion each year
    A 20% reduction in drug-resistant infections would save between 5.7 and 11.3 million additional hospital days and between $3.2 and $5.2 billion in healthcare costs, each year.  
  • Negative value of antibiotics to drug companies
    The value of an antibiotic to a drug company is negative $50 million- compared to the positive value of $1 billion for a new musculoskeletal drug.  
  • Economic value from flu vaccine in elderly
    As over 60% of the economic burden of influenza falls on those ages 65 and older, programs to reduce the impact of influenza on older Americans would have the greatest…  
  • Potential savings from shingles vaccine
    Use of the shingles vaccine in immunocompetent adults ages 60 and older could save between $82 and $103 million in healthcare costs associated with the diagnosis and treatment of shingles,…  
  • Savings from flu vaccine
    Vaccination for influenza resulted in an average annual cost savings of $13.66 per healthy working adult vaccinated.